Fine-tuning of Th17 Cytokines in Periodontal Disease by IL-10

被引:24
|
作者
Moretti, S. [1 ]
Bartolommei, L. [1 ]
Galosi, C. [1 ]
Renga, G. [1 ]
Oikonomou, V. [1 ]
Zamparini, F. [1 ]
Ricci, G. [2 ]
Borghi, M. [1 ]
Puccetti, M. [1 ]
Piobbico, D. [1 ]
Eramo, S. [3 ]
Conti, C. [4 ]
Lomurno, G. [4 ]
Bartoli, A. [1 ]
Napolioni, V. [1 ]
Romani, L. [1 ]
机构
[1] Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy
[2] Univ Perugia, Dept Vet Pathol, I-06132 Perugia, Italy
[3] Univ Perugia, Dept Surg & Biochem Sci, I-06132 Perugia, Italy
[4] Osped Santa Maria Misericordia, Dent Clin, Perugia, Italy
关键词
infection; innate immunity; inflammation; immunopathology; animal studies; genetic polymorphism; GINGIVAL CREVICULAR FLUID; T-CELL RESPONSE; PORPHYROMONAS-GINGIVALIS; EXPRESSION; INTERLEUKIN-10; POLYMORPHISMS; INFLAMMATION; RECRUITMENT; DISRUPTION; ACTIVATION;
D O I
10.1177/0022034515591790
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Periodontitis (PD) is a chronic disease caused by the host inflammatory response to bacteria colonizing the oral cavity. In addition to tolerance to oral microbiome, a fine-tuned balance of IL-10 levels is critical to efficiently mount antimicrobial resistance without causing immunopathology. Clinical and animal studies support that adaptive T-helper (Th) cytokines are involved in the pathogenesis of alveolar bone destruction in PD. However, it remains unclear what type of Th response is related to human PD progression and what role IL-10 has on this process. We addressed the contribution of IL-10 in limiting Th1 and Th17 inflammatory response in murine and human PD. Through a combination of basic and translational approaches involving selected cytokine-deficient mice as well as human genetic epidemiology, our results demonstrate the requirement for IL-10 in fine-tuning the levels of Th17 (IL-17A and IL-17F) cytokines in experimental and human PD. Of novelty, we found that IL-17F correlated with protection in murine and human PD and was positively regulated by IL-10. To our knowledge, this is the first demonstration of the protective role for IL-17F in PD, its positive regulation by IL-10, and the potential differential role for IL-17A and IL-17F in periodontal disease.
引用
收藏
页码:1267 / 1275
页数:9
相关论文
共 50 条
  • [21] Role of Th17 cells and IL-17, IL-23 cytokines in pathogenesis of autoimmune thyroid disease in children
    Artur Bossowski
    M Moniuszko
    M Dabrowska
    M Rusak
    M Jeznach
    A Bodzenta-Łukaszyk
    A Bossowska
    Thyroid Research, 6 (Suppl 2)
  • [22] Th17 cytokines and arthritis
    Lubberts, Erik
    SEMINARS IN IMMUNOPATHOLOGY, 2010, 32 (01) : 43 - 53
  • [23] Th17 cytokines and arthritis
    Erik Lubberts
    Seminars in Immunopathology, 2010, 32 : 43 - 53
  • [24] IL-10 family of cytokines
    Sabat, Robert
    CYTOKINE & GROWTH FACTOR REVIEWS, 2010, 21 (05) : 315 - 324
  • [25] Synergy of IL-23 and Th17 Cytokines: New Light on Inflammatory Bowel Disease
    Shen, Wei
    Durum, Scott K.
    NEUROCHEMICAL RESEARCH, 2010, 35 (06) : 940 - 946
  • [26] Synergy of IL-23 and Th17 Cytokines: New Light on Inflammatory Bowel Disease
    Wei Shen
    Scott K. Durum
    Neurochemical Research, 2010, 35 : 940 - 946
  • [27] Leishmania infection and study of cytokines IL-17, IL-22 (Th17 cells)
    Seyyedan, Jasbi Ehsan
    Miramin, Mohammadi Akram
    Eskandari, Ebrahim
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S164 - S165
  • [28] Changes of Th17 cells, regulatory T cells, Treg/Th17, IL-17 and IL-10 in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Changyan Zi
    Lisha He
    Huan Yao
    Yuan Ren
    Tingting He
    Yongxiang Gao
    Endocrine, 2022, 76 : 263 - 272
  • [29] Changes of Th17 cells, regulatory T cells, Treg/Th17, IL-17 and IL-10 in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Zi, Changyan
    He, Lisha
    Yao, Huan
    Ren, Yuan
    He, Tingting
    Gao, Yongxiang
    ENDOCRINE, 2022, 76 (02) : 263 - 272
  • [30] Butyrate inhibit collagen-induced arthritis via Treg/IL-10/Th17 axis
    Hui, Wenpeng
    Yu, Dapeng
    Cao, Zhong
    Zhao, Xiwu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 68 : 226 - 233